Literature DB >> 25585043

Re-editing the paradigm of Cytidine (C) to Uridine (U) RNA editing.

Nicolas Fossat1, Patrick P L Tam.   

Abstract

Cytidine (C) to Uridine (U) RNA editing is a post-trancriptional modification that until recently was known to only affect Apolipoprotein b (Apob) RNA and minimally require 2 components of the C to U editosome, the deaminase APOBEC1 and the RNA-binding protein A1CF. Our latest work has identified a novel RNA-binding protein, RBM47, as a core component of the editosome, which can substitute A1CF for the editing of ApoB mRNA. In addition, new RNA species that are subjected to C to U editing have been identified. Here, we highlight these recent discoveries and discuss how they change our view of the composition of the C to U editing machinery and expand our knowledge of the functional attributes of C to U RNA editing.

Entities:  

Keywords:  A1CF; APOBEC1; Apolipoprotein b; Intestine; RBM47; RNA editing

Mesh:

Substances:

Year:  2014        PMID: 25585043      PMCID: PMC4615559          DOI: 10.1080/15476286.2014.996054

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  50 in total

1.  The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules.

Authors:  Susan L Kozak; Mariana Marin; Kristine M Rose; Cory Bystrom; David Kabat
Journal:  J Biol Chem       Date:  2006-08-03       Impact factor: 5.157

2.  The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours.

Authors:  Kirsten K Youngren; Douglas Coveney; Xiaoning Peng; Chitralekha Bhattacharya; Laura S Schmidt; Michael L Nickerson; Bruce T Lamb; Jian Min Deng; Richard R Behringer; Blanche Capel; Edward M Rubin; Joseph H Nadeau; Angabin Matin
Journal:  Nature       Date:  2005-05-19       Impact factor: 49.962

3.  Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.

Authors:  A Mehta; M T Kinter; N E Sherman; D M Driscoll
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

4.  Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex.

Authors:  H Lellek; R Kirsten; I Diehl; F Apostel; F Buck; J Greeve
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

5.  Targeted deletion of the murine apobec-1 complementation factor (acf) gene results in embryonic lethality.

Authors:  Valerie Blanc; Jeffrey O Henderson; Elizabeth P Newberry; Susan Kennedy; Jianyang Luo; Nicholas O Davidson
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

6.  ApoB mRNA editing is mediated by a coordinated modulation of multiple apoB mRNA editing enzyme components.

Authors:  Zhigang Chen; Thomas L Eggerman; Amy P Patterson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-08-17       Impact factor: 4.052

7.  Functional antagonism between RNA binding proteins HuR and CUGBP2 determines the fate of COX-2 mRNA translation.

Authors:  Sripathi M Sureban; Nabendu Murmu; Pavel Rodriguez; Randal May; Reeti Maheshwari; Brian K Dieckgraefe; Courtney W Houchen; Shrikant Anant
Journal:  Gastroenterology       Date:  2006-12-19       Impact factor: 22.682

8.  Deletion of the AU-rich RNA binding protein Apobec-1 reduces intestinal tumor burden in Apc(min) mice.

Authors:  Valerie Blanc; Jeffrey O Henderson; Rodney D Newberry; Yan Xie; Soo-Jin Cho; Elizabeth P Newberry; Susan Kennedy; Deborah C Rubin; Hanlin L Wang; Jianyang Luo; Nicholas O Davidson
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

9.  Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins.

Authors:  Sarah Gallois-Montbrun; Rebecca K Holmes; Chad M Swanson; Mireia Fernández-Ocaña; Helen L Byers; Malcolm A Ward; Michael H Malim
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

10.  Mouse apolipoprotein B editing complex 3 (APOBEC3) is expressed in germ cells and interacts with dead-end (DND1).

Authors:  Chitralekha Bhattacharya; Sita Aggarwal; Madhu Kumar; Amatul Ali; Angabin Matin
Journal:  PLoS One       Date:  2008-05-28       Impact factor: 3.240

View more
  7 in total

Review 1.  When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference.

Authors:  Yumeng Wang; Han Liang
Journal:  Bioessays       Date:  2017-12-27       Impact factor: 4.345

2.  Harnessing Nature's Molecular Recognition Capabilities to Map and Study RNA Modifications.

Authors:  Ansley S Felix; Alexandria L Quillin; Shikufa Mousavi; Jennifer M Heemstra
Journal:  Acc Chem Res       Date:  2022-07-28       Impact factor: 24.466

3.  Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain.

Authors:  Ke Shi; Michael A Carpenter; Kayo Kurahashi; Reuben S Harris; Hideki Aihara
Journal:  J Biol Chem       Date:  2015-09-28       Impact factor: 5.157

4.  The Antiviral and Cancer Genomic DNA Deaminase APOBEC3H Is Regulated by an RNA-Mediated Dimerization Mechanism.

Authors:  Nadine M Shaban; Ke Shi; Kate V Lauer; Michael A Carpenter; Christopher M Richards; Daniel Salamango; Jiayi Wang; Michael W Lopresti; Surajit Banerjee; Rena Levin-Klein; William L Brown; Hideki Aihara; Reuben S Harris
Journal:  Mol Cell       Date:  2017-12-28       Impact factor: 17.970

Review 5.  A mark of disease: how mRNA modifications shape genetic and acquired pathologies.

Authors:  Eliana Destefanis; Gülben Avşar; Paula Groza; Antonia Romitelli; Serena Torrini; Pınar Pir; Silvestro G Conticello; Francesca Aguilo; Erik Dassi
Journal:  RNA       Date:  2020-12-29       Impact factor: 4.942

6.  RNA editing generates cellular subsets with diverse sequence within populations.

Authors:  Dewi Harjanto; Theodore Papamarkou; Chris J Oates; Violeta Rayon-Estrada; F Nina Papavasiliou; Anastasia Papavasiliou
Journal:  Nat Commun       Date:  2016-07-15       Impact factor: 14.919

7.  Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B.

Authors:  Ke Shi; Michael A Carpenter; Surajit Banerjee; Nadine M Shaban; Kayo Kurahashi; Daniel J Salamango; Jennifer L McCann; Gabriel J Starrett; Justin V Duffy; Özlem Demir; Rommie E Amaro; Daniel A Harki; Reuben S Harris; Hideki Aihara
Journal:  Nat Struct Mol Biol       Date:  2016-12-19       Impact factor: 15.369

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.